Wai Yuen Tong Medicine Holdings Ltd.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG9421Y2332
HKD
0.37
0.03 (8.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Wai Yuen Tong Medicine Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
3.00
-16.00
-8.00
-48.00
-307.00
439.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
27.00
-86.00
-35.00
-75.00
299.00
-47.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
125.00
100.00
88.00
116.00
358.00
9.00
Cash Flow from Investing Activities
231.00
-139.00
17.00
-15.00
-81.00
337.00
Cash Flow from Financing Activities
-384.00
-318.00
-67.00
-115.00
-266.00
-36.00
Net Cash Inflow / Outflow
-27.00
-366.00
27.00
17.00
44.00
303.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-8.00
-12.00
32.00
34.00
-6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wai Yuen Tong Medicine Holdings Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
3.03
389.838243247704
-386.00
-99.22%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
27.412
-494.402570911804
521.00
105.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
125.894
589.469301797286
-464.00
-78.64%
Cash Flow from Investing Activities
231.805
-119.716395572031
350.00
293.63%
Cash Flow from Financing Activities
-384.563
-318.899080177566
-66.00
-20.59%
Net Cash Inflow / Outflow
-27.037
158.70253852426
-185.00
-117.04%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.173
7.84871247656759
-7.00
-102.20%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 25.69% vs 12.92% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
125.89
100.16
25.69%